Earlier today BioNTech and Pfizer announced that they have produced a vaccine that is 90% effective, far higher than anticipated.


This is great news. However, some have pointed out the timing is quite odd. This announcement before the election likely would have been a giant boost to President Trump.

According to a report from Statnews, Pfizer knew about how effective this vaccine was weeks ago.


Statnews:

Gruber said that Pfizer and BioNTech had decided in late October that they wanted to drop the 32-case interim analysis. At that time, the companies decided to stop having their lab confirm cases of Covid-19 in the study, instead leaving samples in storage. The FDA was aware of this decision. Discussions between the agency and the companies concluded, and testing began this past Wednesday. When the samples were tested, there were 94 cases of Covid in the trial. The DSMB met on Sunday.

This means that the statistical strength of the result is likely far stronger than was initially expected. It also means that if Pfizer had held to the original plan, the data would likely have been available in October, as its CEO, Albert Bourla, had initially predicted.

President and CEO for the Center for Security Policy Fred Fleitz also called this out:

Answers are certainly needed.

The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri two years ago at the age of 19. Since its founding, it has gotten over 2M pages views and over 20k followers. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions.

Click To Go To ProTrumpNews.com

CLICK TO SUPPORT US AND BUY OUR SHIRTS

Share Your Thoughts

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please hover over that comment, click the ∨ icon, and mark it as spam. Thank you for partnering with us to maintain fruitful conversation.